相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays
Bruno Ramos-Molina et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Novel Furin Inhibitors with Potent Anti-infectious Activity
Kornelia Hardes et al.
CHEMMEDCHEM (2015)
Therapeutic uses of furin and its inhibitors: a patent review
Frederic Couture et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
Maurizio Ghisoli et al.
MOLECULAR THERAPY (2015)
Summary of bi-shRNA(furin)/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG (TM)) in Advanced Cancer of the Liver
John Nemunaitis et al.
ONCOLOGY (2014)
Regulation of TGFβ and related signals by precursor processing
Daniel B. Constam
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
The Multifaceted Proprotein Convertases: Their Unique, Redundant, Complementary, and Opposite Functions
Nabil G. Seidah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Alterations in Gene Expression of Proprotein Convertases in Human Lung Cancer Have a Limited Number of Scenarios
Ilya V. Demidyuk et al.
PLOS ONE (2013)
Phase I Trial of bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell Vaccine (FANG) in Advanced Cancer
Neil Senzer et al.
MOLECULAR THERAPY (2012)
Molecular Validation of PACE4 as a Target in Prostate Cancer
Francois D'Anjou et al.
TRANSLATIONAL ONCOLOGY (2011)
Inhibition of the Proprotein Convertases Represses the Invasiveness of Human Primary Melanoma Cells with Altered p53, CDKN2A and N-Ras Genes
Claude Lalou et al.
PLOS ONE (2010)
Proprotein Convertase Inhibition Results in Decreased Skin Cell Proliferation, Tumorigenesis, and Metastasis
Daniel E. Bassi et al.
NEOPLASIA (2010)
A Novel Enediynyl Peptide Inhibitor of Furin That Blocks Processing of proPDGF-A, B and proVEGF-C
Ajoy Basak et al.
PLOS ONE (2009)
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells
Nathalie Scamuffa et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Inhibition of proprotein convertases: Approaches to block squamous carcinoma development and progression
Ricardo Lopez de Cicco et al.
MOLECULAR CARCINOGENESIS (2007)
Proprotein convertases:: lessons from knockouts
Nathalie Scamuffa et al.
FASEB JOURNAL (2006)
Proprotein convertases: Master switches in the regulation of tumor growth and progression
DE Bassi et al.
MOLECULAR CARCINOGENESIS (2005)
Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases
G Siegfried et al.
ONCOGENE (2005)
Curbing activation: proprotein convertases in homeostasis and pathology
NA Taylor et al.
FASEB JOURNAL (2003)
The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis
G Siegfried et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Furin at the cutting edge: From protein traffic to embryogenesis and disease
G Thomas
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells
DE Bassi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells -: Importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions
AM Khatib et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Processing of immunosuppressive pro-TGF-β1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases
J Leitlein et al.
JOURNAL OF IMMUNOLOGY (2001)
Evidence that furin is an authentic transforming growth factor-beta 1-converting enzyme
CM Dubois et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases
I Yana et al.
MOLECULAR BIOLOGY OF THE CELL (2000)